Subcutaneous anakinra in the management of refractory MIS-C in France

Subcutaneous anakinra in the management of refractory MIS-C in France

IntroductionMultisystemic inflammatory syndrome in children (MIS-C) is a therapeutic emergency and can lead to myocardial dysfunction (17%–75%) and heart failure (52%–53%). Intravenous immunoglobulins (IVIG) and corticosteroids (CST) have been validated for the management of this condition. Recent r...

Full description

Bibliographic Details
Main Authors: Perrine Dusser, Alexandre Belot, Fanny Bajolle, Charlotte Kevorkian-Verguet, Ulrich Meinzer, Frédéric Huet, Soizic Tiriau, Isabelle Kone-paut
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pediatrics
Subjects:
COVID-19
epidemiology
multisystem inflammatory syndrome in children
myocarditis
anakinra
interleukin-1
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2024.1270878/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2024.1270878/full

Similar Items